4.7 Article

COPD in Never Smokers Results From the Population-Based Burden of Obstructive Lung Disease Study

期刊

CHEST
卷 139, 期 4, 页码 752-763

出版社

ELSEVIER
DOI: 10.1378/chest.10-1253

关键词

-

资金

  1. ALTANA
  2. Aventis
  3. AstraZeneca
  4. Boehringer-Ingleheim
  5. Chiesi
  6. GlaxoSmithKline
  7. Merck
  8. Novartis
  9. Pfizer Inc
  10. Schering-Plough
  11. Sunovion Pharmaceuticals Inc
  12. University of Kentucky
  13. Schering Plough
  14. Sepracor
  15. AstraZeneca, Spain

向作者/读者索取更多资源

Background: Never smokers comprise a substantial proportion of patients with COPD. Their characteristics and possible risk factors in this population are not yet well defined. Methods: We analyzed data from 14 countries that participated in the international, population-based Burden of Obstructive Lung Disease (BOLD) study. Participants were aged >= 40 years and completed postbronchodilator spirometry testing plus questionnaires about respiratory symptoms, health status, and exposure to COPD risk factors. A diagnosis of COPD was based on the postbronchodilator FEV1/FVC ratio, according to current GOLD (Global Initiative for Obstructive Lung Disease) guidelines. In addition to this, the lower limit of normal (LLN) was evaluated as an alternative threshold for the FEV1/FVC ratio. Results: Among 4,291 never smokers, 6.6% met criteria for mild (GOLD stage I) COPD, and 5.6% met criteria for moderate to very severe (GOLD stage II+) COPD. Although never smokers were less likely to have COPD and had less severe COPD than ever smokers, never smokers nonetheless comprised 23.3% (240/1,031) of those classified with GOLD stage II+ COPD. This proportion was similar, 20.5% (171/832), even when the LLN was used as a threshold for the FEV1/FVC ratio. Predictors of COPD in never smokers include age, education, occupational exposure, childhood respiratory diseases, and BMI alterations. Conclusion: This multicenter international study confirms previous evidence that never smokers comprise a substantial proportion of individuals with COPD. Our data suggest that, in addition to increased age, a prior diagnosis of asthma and, among women, lower education levels are associated with an increased risk for COPD among never smokers. CHEST 2011; 139(4):752-763

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据